On the issue of morphological changes in the kidneys when using nasvay


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a clinical observation and a review of the literature on kidney damage with long-term use of smokeless tobacco (nasvay). nasvay is a type of smokeless tobacco containing over 2000 chemical compounds classified as strong carcinogens. The production of nasvay in the central Asian countries is not controlled, and the composition is not regulated. on the example of a clinical case, the rapid course of nephrotic syndrome, specific kidney damage according to biopsy data and a poor prognosis are demonstrated.

Full Text

Restricted Access

About the authors

Dinara A. Ayypova

National Center for Cardiology and Therapy

Email: dinaralievna@gmail.com
Head of the Department of Nephrology and Gastroenterology Bishkek, Kyrgyzstan

Ayim K. Mukanbaeva

National Center for Cardiology and Therapy

Email: mkn95ak@gmail.com
Junior Researcher Bishkek, Kyrgyzstan

Nazira A. Beishebaeva

National Center of Maternity and Childhood Care

Email: beishebaevanasira@gmail.com
Cand. Sci. (Med.), Head of the Department of Nephrology Bishkek, Kyrgyzstan

Rysbek R. Kaliev

Kyrgyz State Medical Academy

Email: karys2002@mail.ru
Dr. Sci. (Med.), Professor at the Department of Faculty Therapy Bishkek, Kyrgyzstan

References

  1. National Cancer Institute, Centers for Disease Control and Prevention. Smokeless tobacco and public health: a global perspective. Bethesda (MD): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute; 2014 (NIH Publication No. 14-7983; https://cancercontrol.cancer.gov/brp/tcrb/global-perspective/SmokelessTobaccoAndPublicHealth.pdf).
  2. Всемирный день без табака 2018: Табак губит сердце. Выбирайте здоровье, а не табак. Женева: Всемирная организация здравоохранения, 2018 (http://apps.who.int/iris/bitstream/handle/10665/272858/ WHO-NMH-PND-18.4-rus.pdf?sequence = 1&isAllowed=y).
  3. Научно-консультативный комитет по регулированию табачных изделий. Инициатива ВОЗ по освобождению от табачной зависимости. Рекомендации в отношении изделий из бездымного табака. Женева: Всемирная организация здравоохранения. 2003.
  4. (http://apps.who.int/iris/bitstream/handle/10665/42658/9241590556_rus.pdf?sequence=4&isAllowed=y). [Scientific Advisory Committee on Tobacco Products Regulation. The WHO initiative to get rid of tobacco addiction. Recommendations for smokeless tobacco products. Geneva: World Health Organization. 2003.
  5. (http://apps.who.int/iris/bitstream/handle/10665/42658/9241590556_rus.pdf?sequence=4&isAllowed=y) (In Russ.)].
  6. Глобальный доклад ВОЗ о тенденциях в области употребления табака в период между 2000 и 2025 гг. Второе издание. Женева: Всемирная организация здравоохранения, 2018 (http://apps.who.int/iris/bitstream/handle/10665/258555/WHO-NMH-PND-17.4-rus.pdf?sequence=1&isAllo wed=y).
  7. Stepanov I., Abrams J., Jain V. еt al. Variations of toxic and carcinogenic constituents in nasvai: call for systematic research and regulation. Tob. Control. 2017;26:355-6. http://tobaccocontrol.bmj.com/content/26/3/355.
  8. Begum S.F., Nagajothi G., Swarnalatha K. Chronic smokeless tobacco consumption contributes to the development of renal diseases in the human male volunteers. J. Anal. Pharm. Res. 2018;7(6): 652-62. Doi: 10.15406/ japlr.2018.07.00297.
  9. Yu Ch., Zhang Z., Liu Y., et al. Toxicity of Smokeless Tobacco Extract after 184-Day Repeated Oral Administration in Rats. Journal List. Int. J. Environ Res. Publ. Healthy. 2016:13(3);MarPMC4808944.
  10. Joyce E., Glasner P., Ranganathan S., et al. Tubulointerstitial Nephritis: Diagnosis, Treatment and Monitoring. Pediatr. Nephrol. 2017;32(4):577-87. Published on-line 2016 May 7. doi: 10.1007/s00467-016-3394-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download